NCT05024968 2026-02-25Sintilimab in Cancer of Unknown PrimaryM.D. Anderson Cancer CenterPhase 2 Completed10 enrolled 9 charts
NCT02937116 2022-10-14First in Human Study of IBI308 in Chinese Subjects With Advanced Solid TumorsInnovent Biologics (Suzhou) Co. Ltd.Phase 1 Completed233 enrolled 30 charts